PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI‐CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL). (June 2017)

• Record Type: Journal Article
• Authors: Neelapu, S.S.; Rossi, J.M.; Locke, F.L.; Xue, A.; Better, M.; Zhang, X.; Ghobadi, A.; Lekakis, L.J.; Miklos, D.; Jacobson, C.A.; Braunschweig, I.; Oluwole, O.; Siddiqi, T.; Lin, Y.; Timmerman, J.; Reagan, P.M.; Navale, L.; Go, W.Y.; Wiezorek, J.; Bot, A.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 262
• Page End: 263
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_132
• Languages: English
• ISSNs: 0278-0232